跳至主要内容
临床试验/NCT06027996
NCT06027996招募中不适用

Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA)

Melodi Health, Inc.20 个研究点 分布在 1 个国家目标入组 702 人开始时间: 2024年8月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
702
试验地点
20
主要终点
Complications of Breast Reconstruction

研究概览

简要总结

Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 22 or older at the time of enrollment.
  • Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast reconstruction.
  • Is able to and willing to comply with the study requirements and providing informed consent.

排除标准

  • Has prior history of neoadjuvant radiotherapy.
  • Has had prior history of failed tissue expansion or breast implantation at the intended reconstruction site.
  • Has an active abscess or infection requiring antibiotics anywhere in their body within 30 days.
  • Has a Body Mass Index (BMI) < 14 or >
  • Is pregnant or is nursing; or plans to become pregnant during the course of the study.
  • Has any connective tissue/autoimmune disorder or rheumatoid disease.
  • Has known allergies to study device materials.
  • Is participating in another interventional research study that may interfere with study endpoints.
  • Has limited life expectancy or co-morbid conditions, social/psychological problems, or cognitive impairments that precludes participation.
  • Has a medical condition or is taking medications that would result in elevated risk and/or affect the validity of the study.
  • Intraoperative assessment demonstrates unfavorable conditions (i.e., poor mastectomy skin flap thickness or viability) for immediate, two-stage post-mastectomy alloplastic prepectoral reconstruction in any breast.

结局指标

主要结局

Complications of Breast Reconstruction

时间窗: 6 months

Key local complications

次要结局

未报告次要终点

研究者

发起方
Melodi Health, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验